Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients

被引:12
|
作者
Hong, Yi-Wen [1 ]
Lin, Jen-Der [2 ]
Yu, Ming-Chin [1 ]
Hsu, Chih-Chieh [1 ]
Lin, Yann-Sheng [1 ]
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Dept Surg, 5 Fuxing St, Taoyuan 333, Taiwan
[2] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Div Endocrinol & Metab,Dept Internal Med, 5 Fuxing St, Taoyuan 333, Taiwan
关键词
Thyroid cancer; Brain metastasis; Skull metastasis; Radioiodine; Surgery; BRAIN METASTASES; FOLLOW-UP; DISTANT METASTASIS; SKULL METASTASIS; CARCINOMA; PAPILLARY; RADIOIODINE; MANAGEMENT;
D O I
10.1016/j.ijsu.2018.06.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Cranial metastasis of thyroid cancer is rare. The aim of this study was to analyse the clinical characteristics, treatments and outcomes of thyroid cancer patients with cranial metastasis and to identify the associated prognostic factors. Materials and methods: Between January 1977 and August 2017, a total of 4683 patients were histologically confirmed to have thyroid cancer. Among them, 25 patients (0.53%) were identified as having cranial metastases, and their medical records were reviewed. The Kaplan-Meier method with a log-rank test was performed with cancer-specific survival as the main outcome. Cox regression analysis was used to examine the potential prognostic factors influencing patient survival. Results: Of the 25 patients, 21 were female, and 4 were male. The median age at the time of diagnosis of cranial metastasis was 63 years. Sixteen patients had metastases to the brain, and nine patients had metastases involving the skull only. Papillary carcinoma and follicular carcinoma accounted for 84.0% of cases. Twenty-four cases (96.0%) had extracranial metastases at the time of diagnosis of cranial metastases. Twenty patients received surgery, and 4 patients received palliative radiotherapy. One patient received supportive care only. The median cancer-specific survival after the diagnosis of cranial metastases was 27 months. According to the Kaplan-Meier test, 3 factors had a significant impact on survival, the metastatic site, histological types and surgical resection. According to the Cox regression analysis, skull metastases (HR: 0.274, 95% CI: 0.083-0.904, p = 0.033) and surgical resection (HR: 0.134, 95% CI: 0.019-0.929, p = 0.042) were identified as independent prognostic factors for a better outcome. Conclusions: Surgical resection is the mainstay therapy for thyroid cancer patients with cranial metastasis. Cranial metastases involving the skull only are associated with a better outcome.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 50 条
  • [1] SURVIVAL TIME AND PROGNOSTIC FACTORS IN PATIENTS WITH SPINAL METASTASES: A RETROSPECTIVE COHORT AND PROGNOSTIC STUDY
    Piyapromdee, U.
    Adulyanukosol, V.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S374 - S374
  • [2] Treatment outcomes and prognostic factors in nonmetastatic metaplastic breast cancer patients: a multicenter retrospective cohort study
    Puskulluoglu, Mirosiawa
    Konieczna, Aleksandra
    Swiderska, Katarzyna
    Streb, Joanna
    Pieniazek, Maigorzata
    Grela-Wojewoda, Alek-sandra
    Pacholczak-Madej, Renata
    Mucha-Maiecka, Anna
    Mitus, Jerzy W.
    Szpor, Joanna
    Kunkiel, Michai
    Rudzinska, Agnieszka
    Jarzab, Michai
    Ziobro, Marek
    ACTA ONCOLOGICA, 2024, 63 : 620 - 635
  • [3] LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES
    Hirsch, Dania
    Levy, Sigal
    Tsvetov, Gloria
    Gorshtein, Alexander
    Slutzky-Shraga, Ilana
    Akirov, Amit
    Robenshtok, Eyal
    Shimon, Ilan
    Benbassat, Carlos A.
    ENDOCRINE PRACTICE, 2017, 23 (10) : 1193 - 1200
  • [4] Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases
    Bal, Chandra Sekhar
    Garg, Aayushi
    Chopra, Saurav
    Ballal, Sanjana
    Soundararajan, Ramya
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2015, 28 (7-8): : 745 - 751
  • [5] Prognostic factors and survival outcomes in patients with salivary duct carcinoma: a retrospective cohort study
    Chen, Fei
    Li, Liangbo
    Tao, Jingqiao
    Jin, Nenghao
    Wang, Liwei
    Zhu, Liang
    Qiao, Bo
    Xing, Lejun
    Wei, Bo
    Bu, Jingqiu
    Zhang, Haizhong
    BMC ORAL HEALTH, 2025, 25 (01):
  • [6] Long-term outcomes and prognostic factors of patients with obstructive colorectal cancer: A multicenter retrospective cohort study
    Atsushi, Ishibe
    Mitsuyoshi, Ota
    Kazuya, Yamaguchi
    Syuhei, Kaida
    Noriyuki, Kamiya
    Masashi, Momiyama
    Akira, Watanabe
    Kentaro, Sekizawa
    Nobuyuki, Kamimukai
    Natsuko, Sugimasa
    Jun, Watanabe
    Yasushi, Ichikawa
    Chikara, Kunisaki
    Itaru, Endo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (22) : 5237 - 5245
  • [7] Long-term outcomes and prognostic factors of patients with obstructive colorectal cancer: A multicenter retrospective cohort study
    Ishibe Atsushi
    Ota Mitsuyoshi
    Yamaguchi Kazuya
    Kaida Syuhei
    Kamiya Noriyuki
    Momiyama Masashi
    Watanabe Akira
    Sekizawa Kentaro
    Kamimukai Nobuyuki
    Sugimasa Natsuko
    Watanabe Jun
    Ichikawa Yasushi
    Kunisaki Chikara
    Endo Itaru
    World Journal of Gastroenterology, 2016, (22) : 5237 - 5245
  • [8] Brain metastases in breast cancer: a retrospective cohort study of 187 patients and prognostic markers determination
    Svoboda, M.
    Fabian, P.
    Ondrova, A.
    Palacova, M.
    Grell, P.
    Gombosova, J.
    Princ, D.
    Slaby, O.
    Slampa, P.
    R, Vyzula
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S253 - S253
  • [9] Brain Metastases in Gynaecologic Cancer: A Retrospective Cohort Study Evaluating Treatment Outcomes, Prognostic Factors, and Overall Survival
    Cooke, Carly M.
    Babadagli, M. Ege
    Wilson, Hillary
    Nair, Vimoj J.
    Lupe, Krystine
    Malone, Shawn
    Burgess, Laura
    Faught, Wylam
    Samant, Rajiv
    Le, Tien
    CURRENT ONCOLOGY, 2024, 31 (12) : 7575 - 7585
  • [10] Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1 043 patients
    Bollen, Laurens
    van der Linden, Yvette M.
    Pondaag, Willem
    Fiocco, Marta
    Pattynama, Bas P. M.
    Marijnen, Corrie A. M.
    Nelissen, Rob G. H. H.
    Peul, Wilco C.
    Dijkstra, P. D. Sander
    NEURO-ONCOLOGY, 2014, 16 (07) : 991 - 998